An announcement from Huadong Medicine Co.,Ltd. (SZSE: 000963) reveals a proposal by the company's Chairman, Mr. Lv Liang.
The proposal, made under the authority granted by the 2025 annual general meeting of shareholders held on May 20, 2026, and subject to compliance with relevant laws and the company's articles of association, concerns an interim profit distribution plan for 2026.
It is suggested to distribute cash dividends to all shareholders at a rate of 3.50 yuan (including tax) per 10 shares, based on the total share capital on the record date for this future distribution.
The plan does not include bonus share issues or capital reserve conversions into share capital.
Comments